The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: A post hoc analysis of combined clinical trials

Epilepsy Research

Volumn 96, Issue 1-2, 2011, Pages 64-73

  Tomson, Torbjörn ^a   Almas, Mary ^b   Giordano, Suzanne ^b   Cabrera, Javier ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b PFIZER INC   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Combination therapy; Epilepsy; Partial onset seizures; Pregabalin

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; BLURRED VISION; CHILD; CLINICAL TRIAL (TOPIC); CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIPLOPIA; DISEASE CONTROL; DIZZINESS; DOUBLE BLIND PROCEDURE (TOPIC); DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; VERTIGO; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; CLUSTER ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052857740     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.05.001     Document Type: Article

References (20)

1. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., Messmer S. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004, 45:20-27. Pregabalin 1008-011 International Study Group.
2. Baulac M., Leon T., O'Brien T.J., Whalen E., Barrett J. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures. Epilepsy Res. 2010, 91:10-19.
3. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005, 64:475-480. Pregabalin 1008-009 Study Group.
4. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., Hounslow N.J., Bron N.J., Gibson G.L., Bockbrader H.N. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 2005, 46:1407-1413.
5. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
6. Cramer J.A., Fisher R., Ben-Menachem E., French J., Mattson R.H. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999, 40:590-600.
7. Deckers C.L. Overtreatment in adults with epilepsy. Epilepsy Res. 2002, 52:43-52.
8. Deckers C.L., Hekster Y.A., Keyser A., Meinardi H., Renier W.O. Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 1997, 38:570-575.
9. Elger C.E., Brodie M.J., Anhut H., Lee C.M., Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005, 46:1926-1936.
10. French J.A., Faught E. Rational polytherapy. Epilepsia 2009, 50(Suppl. 8):63-68.
11. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003, 60:1631-1637.
12. ILAE/IBE/WHO Global Campaign Against Epilepsy, 2003. Annual Report 2003. Epilepsy Out of the Shadows. ILAE/IBE/WHO Global Campaign Against Epilepsy.
13. Kwan P., Brodie M.J. Epilepsy after the first drug fails: substitution or add-on?. Seizure 2000, 9:464-468.
14. Lee B.I., Yi S., Hong S.B., Kim M.K., Lee S.A., Lee S.K., Shin D.J., Kim J.M., Song H.K., Heo K., Lowe W., Leon T. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Epilepsia 2009, 50:464-474.
15. Mattson R.H. Drug treatment of uncontrolled seizures. Epilepsy Res. 1992, Suppl. 5:29-35.
16. Mohanraj R., Brodie M.J. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur. J. Neurol. 2006, 13:277-282.
17. St Louis E.K. Truly " rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects. Curr. Neuropharmacol. 2009, 7:96-105.
18. Stephen L.J., Brodie M.J. Seizure freedom with more than one antiepileptic drug. Seizure 2002, 11:349-351.
19. US Food and Drug Administration COSTART: Coding Symbols for a Thesaurus of Adverse Event Reaction Terms 1996, US Food and Drug Administration, Rockville, MD. 4th ed.
20. White H.S., Smith M.D., Wilcox K.S. Mechanisms of action of antiepileptic drugs. Int. Rev. Neurobiol. 2007, 81:85-110.